APEX1 and glioblastoma: APE1 may be particularly relevant in glioblastoma (GBM), for which the TMZ alkylator is the preferred chemotherapeutic agent, as the resistance to TMZ is in part mediated by elevated levels of APE1 [61,65,66,67,68,69,70].